evidencegaps
Primary study · included by 1 review

Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study.

Yim 2026 · Yim Ga Won, Han Kyung Hee, Lee Soon Tae, et al. · BMC medicine · 2026

Included by

Selenium supplementation for preventing cancer therapy-related toxicities: a systematic review and meta-analysis of clinical trials.
Non-Cochrane · intervention · 2026 · cited as Yim 2026 · Table 1; reference 19

The review does not say which of its outcomes this study informs.

1 including review in total.